Nasdaq to Delist BNB Treasury Firm Windtree Therapeutics, Stock Crashes 76%
Windtree Therapeutics will be delisted from the Nasdaq Capital Market after failing to meet listing requirements, a decision that triggered a massive sell-off in its stock. Windtree Faces Nasdaq Delisting Over Stock Price, Plans Move to OTC Markets The SEC document showed that Nasdaq notified the firm on August 19, 2025. Trading on its shares
The post Nasdaq to Delist BNB Treasury Firm Windtree Therapeutics, Stock Crashes 76% appeared first on CoinGape.
